Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 25Neoplasms 12Prostatic Neoplasms 9Multiple Myeloma 9Neoplasm Metastasis 7Giant Cell Tumor of Bone 7Osteoporosis 4Fractures, Bone 4Recurrence 3Kidney Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Non-Small-Cell Lung 3Bone Diseases, Metabolic 3Bone Diseases 3Spinal Cord Compression 2Smoldering Multiple Myeloma 2Parathyroid Neoplasms 2Melanoma 2Lymphoma 2Lung Neoplasms 2Bone Neoplasms 2Bone Metastases 2Bone Cysts, Aneurysmal 2With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Thyroid Neoplasms 1Thyroid Cancer Metastatic 1Paraproteinemias 1Pancreatic Neoplasms 1

Interventions

exemestane 7Trastuzumab 7Anastrozole 7Letrozole 6Docetaxel 6palbociclib 5pyrotinib 4entinostat 4Fulvestrant 4Cyclophosphamide 4ribociclib 3abemaciclib 3Tamoxifen 3Doxorubicin 3pertuzumab 2Sodium Chloride 2Paclitaxel 2Lapatinib 2Gonadotropin-Releasing Hormone 2Exercise 2Everolimus 2Epirubicin 2Drug Evaluation 2Capecitabine 2Botulinum Toxins, Type A 2Aromatase Inhibitors 2AZD9833 2trastuzumab deruxtecan 1taxane 1sacubitril and valsartan sodium hydrate drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Breast Diseases × Denosumab × Clear all
NCT04711109 2025-04-02

BRCA-P

Alliance for Clinical Trials in Oncology

Phase 3 Active not recruiting
300 enrolled
Breast

Breast Diseases, Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡